Canadian Guidance for Anaphylaxis Management
|
|
|
|
|
|
2022 GINA Global Strategy for Asthma Management and Prevention Guidelines
|
|
|
|
|
|
Oral Immunotherapy Guidelines
|
|
|
|
|
|
Allergy diagnostics
|
|
|
|
|
|
Allergen immunotherapy
|
|
|
|
|
|
Exercise-induced hypersensitivity syndromes
|
|
|
|
|
|
Treatment and emerging therapies for eosinophilic esophagitis
|
|
|
|
|
|
Immunomodulation and novel therapeutic approaches in allergy
|
|
|
|
|
|
Biologic therapies for asthma
|
|
|
|
|
|
Treatment and management of allergic rhinitis
|
|
|
|
|
|
Treatment and management of allergic eye conditions
|
|
|
|
|
|
Biologics in the management of chronic rhinosinusitis
|
|
|
|
|
|
Managing environmental allergies
|
|
|
|
|
|
Management of urticaria and angioedema
|
|
|
|
|
|
Role of microbiome in allergic diseases
|
|
|
|
|
|
Role of axis communications (e.g. immune-gut axis, skin-gut axis, brain gut axis) in allergy and chronic diseases
|
|
|
|
|
|
Telemedicine in disease management
|
|
|
|
|
|
Managing mental health challenges in asthma and allergic diseases
|
|
|
|
|
|